1. Incorporating AFP-L3 and DCP in selecting patients with hepatocellular carcinoma for liver transplantation: what are the optimal criteria?;Meng;J Hepatol,2023
2. AFP-L3 and DCP strongly predict early hepatocellular carcinoma recurrence after liver transplantation;Norman;J Hepatol,2023
3. DCP and AFP-L3 are complementary to AFP in predicting high-risk explant features: results of a prospective study;Kotwani;Clin Gastroenterol Hepatol,2021
4. OPTN/UNOS policy notice modification to hepatocellular carcinoma (HCC) extension criteria,2018
5. Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria;Hameed;Liver Transpl,2014